These results not onlyemphasized the significance of serum albumin in the prognostic assessment andcare of CHD patients, but also suggested that for individuals withhypoalbuminemia, appropriate supplementation of exogenous albumin might havepotential clinical value in improving the prognosis of patients with CHD and evenCVD. The gene discussed is ALB; the disease is coronary artery disorder.